SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2026 • Anaptysbio, Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2026 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of March 26, 2026, by and among First Tracks Biotherapeutics, Inc., a Delaware corporation (the “Company”), EcoR1 Capital Fund Qualified, L.P. (the “Selling Stockholder”), and each of the entities listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2026 • Vor Biopharma Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 27th, 2026 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of March 26, 2026, by and among Vor Biopharma Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2026 • First Tracks Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2026 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of March 26, 2026, by and among First Tracks Biotherapeutics, Inc., a Delaware corporation (the “Company”), EcoR1 Capital Fund Qualified, L.P. (the “Selling Stockholder”), and each of the entities listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).